Keyphrases
N-methyl-D-aspartate Receptor (NMDAR)
98%
NMDAR1
98%
Ultrastructural Localization
86%
Nucleus Accumbens
86%
Immunoreactivity
70%
Dendrite
59%
Caudate-putamen
52%
Glutamate Receptors
35%
δ Opioid Receptor
34%
Ventral Bed nucleus of the Stria Terminalis (vBNST)
34%
NMDA-type Glutamate Receptor
34%
N-methyl-D-aspartate
28%
Axon Terminal
27%
Retinoic Acid
27%
Inducible Nitric Oxide Synthase
27%
Opiates
26%
Rat Brain
24%
Extended Amygdala
24%
Central Amygdala
24%
Immunohistochemical Localization
22%
Opioid Receptors
22%
Soma
22%
Heroin
20%
Spine
19%
Spiny Projection Neurons
19%
Axon
18%
Tyrosine Hydroxylase
17%
Microinjection
17%
Heroin Self-administration
17%
Co-expression
17%
Sorcin
17%
Calcium-binding Proteins
17%
Ultrastructure
17%
Opiate Withdrawal
17%
C-Fos Immunohistochemistry
17%
Basolateral Amygdala
17%
Globus Pallidus
17%
Synaptic Input
17%
Substance P
17%
Tyrosine
17%
Dynorphin
17%
Research Profile
17%
Messenger RNA (mRNA)
17%
Neuroscience
17%
Inducible Expression
17%
Human Cell Lines
17%
μ-opioid Receptor
17%
Conditioned Place Aversion
17%
NG108-15 Cells
17%
Neuroblastoma
17%
Neuroscience
Aspartic Acid
100%
Nucleus Accumbens
86%
Eicosanoid Receptor
82%
Dendrite
67%
δ -Opioid Receptor
63%
Opiate
60%
Axon
59%
Glutamate Receptor
59%
Putamen
52%
N-Methyl-D-Aspartic Acid
37%
Stria Terminalis
34%
Heroin
34%
Tretinoin
31%
Synapse
27%
Nitric Oxide Synthase
27%
Amygdala
24%
Soma
22%
NMDA Receptor
22%
Behavior (Neuroscience)
21%
Nitrotyrosine
17%
Calcium-Binding Protein
17%
Opioid Antagonist
17%
Globus pallidus
17%
Tyrosine Hydroxylase
17%
Neuroblastoma
17%
Substance P
17%
Dynorphin
17%
Basolateral Amygdala
17%
Cell Line
17%
μ-Opioid Receptor
17%
Sorcin
17%
Dendritic Spine
13%
Nitric Oxide
13%
Antiserum
11%
Peroxidase
10%
Calcium Transport
8%
Central Nucleus of the Amygdala
8%
Neurotransmitter
7%
Electron Microscopy
7%
Dopaminergic
6%
Naloxone
6%
Dopamine Release
6%
Glutamic Acid
5%